Publication | Open Access

Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition

Neuro-oncologyPediatric Bithalamic GliomasDistinct Epigenetic SignaturePediatric Brain TumorsGliomaEpigenetic ChangePathologyCancer GenomicsHigh-grade GliomasKinase InhibitionMedicineCell BiologyTumor Microenvironment